Literature DB >> 21775349

The Danish National Prescription Registry.

Helle Wallach Kildemoes1, Henrik Toft Sørensen, Jesper Hallas.   

Abstract

INTRODUCTION: Individual-level data on all prescription drugs sold in Danish community pharmacies has since 1994 been recorded in the Register of Medicinal Products Statistics of the Danish Medicines Agency. CONTENT: The register subset, termed the Danish National Prescription Registry (DNPR), contains information on dispensed prescriptions, including variables at the level of the drug user, the prescriber, and the pharmacy. VALIDITY AND COVERAGE: Reimbursement-driven record keeping, with automated bar-code-based data entry provides data of high quality, including detailed information on the dispensed drug.
CONCLUSION: The possibility of linkage with many other nationwide individual-level data sources renders the DNPR a very powerful pharmacoepidemiological tool.

Mesh:

Year:  2011        PMID: 21775349     DOI: 10.1177/1403494810394717

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  559 in total

1.  A Nationwide Study in Denmark of the Association Between Treated Infections and the Subsequent Risk of Treated Mental Disorders in Children and Adolescents.

Authors:  Ole Köhler-Forsberg; Liselotte Petersen; Christiane Gasse; Preben B Mortensen; Soren Dalsgaard; Robert H Yolken; Ole Mors; Michael E Benros
Journal:  JAMA Psychiatry       Date:  2019-03-01       Impact factor: 21.596

2.  Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark.

Authors:  H H Nielsen; J Qiu; S Friis; L Wermuth; B Ritz
Journal:  Eur J Neurol       Date:  2012-01-17       Impact factor: 6.089

3.  Do immigrants from Turkey, Pakistan and Ex-Yugoslavia with newly diagnosed type 2 diabetes initiate recommended statin therapy to the same extent as Danish-born residents? A nationwide register study.

Authors:  Diana C Sanchez-Ramirez; Allan Krasnik; Helle Wallach Kildemoes
Journal:  Eur J Clin Pharmacol       Date:  2012-05-31       Impact factor: 2.953

4.  Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study.

Authors:  Wayne Katon; Henrik Sondergaard Pedersen; Anette Riisgaard Ribe; Morten Fenger-Grøn; Dimitry Davydow; Frans Boch Waldorff; Mogens Vestergaard
Journal:  JAMA Psychiatry       Date:  2015-06       Impact factor: 21.596

5.  Use of Antibiotics and Risk of Type 2 Diabetes: A Population-Based Case-Control Study.

Authors:  Kristian Hallundbæk Mikkelsen; Filip Krag Knop; Morten Frost; Jesper Hallas; Anton Pottegård
Journal:  J Clin Endocrinol Metab       Date:  2015-08-27       Impact factor: 5.958

6.  Early development in children that are later diagnosed with disorders of attention and activity: a longitudinal study in the Danish National Birth Cohort.

Authors:  Sanne Lemcke; Erik T Parner; Merete Bjerrum; Per H Thomsen; Marlene B Lauritsen
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-02-09       Impact factor: 4.785

7.  A Danish national population-based cohort study of synthetic midurethral slings, 2007-2011.

Authors:  Margrethe Foss Hansen; Gunnar Lose; Hrefna Bóel Sigurdardòttir; Kim Oren Gradel
Journal:  Int Urogynecol J       Date:  2018-08-02       Impact factor: 2.894

8.  Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.

Authors:  Anja Thormann; Melinda Magyari; Nils Koch-Henriksen; Bjarne Laursen; Per Soelberg Sørensen
Journal:  J Neurol       Date:  2016-10-03       Impact factor: 4.849

9.  Participation in questionnaire studies among couples affected by breast cancer.

Authors:  Helene Terp; Nina Rottmann; Pia Veldt Larsen; Mariët Hagedoorn; Henrik Flyger; Niels Kroman; Christoffer Johansen; Susanne Dalton; Dorte Gilså Hansen
Journal:  Support Care Cancer       Date:  2014-12-10       Impact factor: 3.603

10.  Adherence to preventive statin therapy according to socioeconomic position.

Authors:  Helle Wallach-Kildemoes; Morten Andersen; Finn Diderichsen; Theis Lange
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.